TELA Bio (TELA) Gross Margin (2018 - 2026)

TELA Bio has reported Gross Margin for 9 years, with the latest figure at 72.28% in Q2 2026.

• On a quarterly basis, Gross Margin rose 244.0% year-over-year to 72.28% in Q2 2026; TTM through Jun 2026 was 67.81%, a 51.0% increase from a year earlier, with the FY2025 full-year figure at 67.69%, up 61.0% from the prior year.
• Gross Margin was 72.28% for Q2 2026 at TELA Bio, up from 65.69% in the prior quarter.
• The five-year high for Gross Margin was 72.28% in Q2 2026, with the low at 60.73% in Q1 2022.
• Average Gross Margin over 5 years is 67.28%, with a median of 67.69% recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Gross Margin surged 744 bps in 2023, then plunged 481 bps in 2024.
• Over 5 years, Gross Margin stood at 70.35% in 2022, then slipped by 3 bps to 68.38% in 2023, then declined by 7 bps to 63.58% in 2024, then increased by 4 bps to 65.91% in 2025, then climbed by 10 bps to 72.28% in 2026.
• The last three Gross Margin figures came in at 72.28% (Q2 2026), 65.69% (Q1 2026), and 65.91% (Q4 2025), per Business Quant data.